Frankfurt
15.04.26 | 08:03
8,900 Euro
-0,22 % -0,020
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,780 | 9,130 | 14:53 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.03. | Nexstim Oyj: Nexstim Plc: Resolutions of the Annual General Meeting | 100 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 March 2026 at 1:30 PM (EEST)
Nexstim Plc: Resolutions of the Annual General Meeting
Nexstim Plc ("Nexstim" or "Company") announces the following resolutions of the... ► Artikel lesen | |
| NEXSTIM Aktie jetzt für 0€ handeln | |||||
| 23.03. | Nexstim Oyj: Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD) | 242 | GlobeNewswire (Europe) | Press release, Helsinki, 23 March 2026 at 10:30 AM (EET)
Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)
Nexstim Plc ("Nexstim" or "Company") announces... ► Artikel lesen | |
| 26.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2025 | 467 | GlobeNewswire (Europe) | Company announcement, Helsinki 26 February 2026 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2025
NEXSTIM ACCELERATED GROWTH AND ACHIEVED A PROFITABLE RESULT
January-December 2025
The... ► Artikel lesen | |
| 19.02. | Nexstim Oyj: Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation | 184 | GlobeNewswire (Europe) | Press release, Helsinki, 19 February 2026 at 9 AM (EET)
Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation
Nexstim Plc ("Nexstim" or "Company") has... ► Artikel lesen | |
| 16.02. | Nexstim Oyj: Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE | 370 | GlobeNewswire (Europe) | Press release, Helsinki, 16 February 2026 at 11:30 AM (EET)
Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE
Nexstim Plc ("Nexstim" or "Company") has received import clearance for... ► Artikel lesen | |
| 02.02. | Nexstim Oyj: Nexstim Receives System Order from Distributor in India | 228 | GlobeNewswire (Europe) | Press release, Helsinki, 2 February 2026 at 9 AM (EET)
Nexstim Receives System Order from Distributor in India
Nexstim Plc ("Nexstim" or "Company") has received an order for an NBS System 5 through... ► Artikel lesen | |
| 30.12.25 | Nexstim Receives U.S. Order For Two NBS 6 Therapy Systems | 5 | RTTNews | ||
| 30.12.25 | Nexstim Oyj: US Customer Orders Two Nexstim NBS 6 Therapy Systems | 378 | GlobeNewswire (Europe) | Press release, Helsinki, 30 December 2025 at 9 AM (EET)
US Customer Orders Two Nexstim NBS 6 Therapy Systems
Nexstim Plc ("Nexstim" or "Company") has received an order for two NBS 6 therapy systems... ► Artikel lesen | |
| 23.12.25 | Nexstim Oyj: Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc. | 192 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 23 December 2025 at 9 AM (EET)
Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc.
Nexstim Plc ("Nexstim"... ► Artikel lesen | |
| 16.09.25 | Nexstim Oyj: Nexstim Receives NBS 5+ System Order from Therapy Customer in United States | 196 | GlobeNewswire (Europe) | Press release, Helsinki, 16 September 2025 at 9 AM (EEST)
Nexstim Receives NBS 5+ System Order from Therapy Customer in United States
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an... ► Artikel lesen | |
| 15.08.25 | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2025 (unaudited) | 238 | GlobeNewswire (Europe) | NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2025 (UNAUDITED)
Company announcement, Helsinki, August 15, 2025 at 9 am (EEST)
NEXSTIM ACCELERATED GROWTH AND IMPROVED PROFITABILITY IN THE FIRST HALF... ► Artikel lesen | |
| 08.08.25 | Nexstim Oyj: Nexstim Receives NBS System 5 Order from India | 384 | GlobeNewswire (Europe) | Press release, Helsinki, 8 August 2025 at 10 AM (EEST)
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from an Indian distributor.
The end customer is a hospital... ► Artikel lesen | |
| 30.06.25 | Nexstim Oyj: Nexstim Plc Signs Exclusivity Agreement with Sinaptica Therapeutics, Inc. as Part of Planned Alzheimer's Collaboration | 173 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 June 2025 at 9 AM (EEST)
Nexstim Plc Signs Exclusivity Agreement with Sinaptica Therapeutics, Inc. as Part of Planned Alzheimer's Collaboration
Nexstim Plc (NXTMH:HEX)... ► Artikel lesen | |
| 23.06.25 | Nexstim Oyj: Nexstim Receives NBS System 5 Order from a University Hospital in Germany | 270 | GlobeNewswire (Europe) | Press release, Helsinki, 23 June 2025 at 9 AM (EEST)
Nexstim Receives NBS System 5 Order from a University Hospital in Germany
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order... ► Artikel lesen | |
| 05.05.25 | Nexstim Oyj: Nexstim Plc Business Update Q1 2025 | 346 | GlobeNewswire (Europe) | Press release, Helsinki, 5 May 2025, at 9 AM (EEST)
Nexstim Plc Business Update Q1 2025
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces the key highlights of the Company's business operations... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| VERU | 2,420 | 0,00 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| NYXOAH | 2,645 | +4,75 % | Stifel senkt Kursziel für Nyxoah-Aktie nach Neubewertung auf 8 US-Dollar | ||
| OPTOMED | 2,330 | +2,87 % | OPTOMED OYJ: Notice Of The Annual General Meeting Of Optomed Plc | ||
| MODULIGHT | 1,020 | +0,49 % | Modulight Oyj: Record Year in Revenue Growth | Modulight Corporation | Company Release | February 20, 2026 at 11:00:00 EET
This release is a summary of Modulight's financial statements bulletin 2025. The whole report is attached to this stock exchange... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,280 | 0,00 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| FRESENIUS MEDICAL CARE | 38,930 | -1,82 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 17,170 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| FRESENIUS | 44,690 | -0,36 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| SIEMENS HEALTHINEERS | 38,550 | +0,68 % | Multinational Execs in China Must Act as Entrepreneurs, Siemens Healthineers Country President Says | ||
| BRIGHTSPRING HEALTH SERVICES | 46,040 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,220 | +0,44 % | Carl Zeiss Meditec: Starkes Lebenszeichen - Analysten erwarten kräftige Gewinne | ||
| ECKERT & ZIEGLER | 15,610 | -0,57 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106 Augenapplikatoren | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106... ► Artikel lesen | |
| HEARTFLOW | 29,020 | 0,00 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen |
NEXSTIM OYJ gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,020 (-0,22 %) liegt der Kurs bei 8,900 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXSTIM OYJ finden Sie auf Wallstreet Online.